Orphan drug specialist Horizon looks to double down on its gout expertise with acquired rights to Arrowhead's RNAi med

Horizon Therapeutics has made a name for taking orphan drugs once left on the scrap heap and spinning them into approved therapies. Along the way …

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Or­phan drug spe­cial­ist Hori­zon looks to dou­ble down on its gout ex­per­tise with ac­quired rights to Ar­row­head­'s RNAi med